Technology Transfer Service
Bestbiochem seeks new drug projects from biotech companies and universities around the world, then introduces projects to pharmaceuticals and investors. We play as a communication node between researchers and pharmaceuticals, improve the speed of technology circulation.
As a third part technology transfer organization, we consider for both sides and keep honest, responsible during service.
Our services include: technology transfer, technology investment, merger and acquisition.
We focus on these areas: new drugs, new targets, generic drugs, innovative therapies, etc.
If you have projects need license-in or license-out, please contact us: email@example.com
|BCW100001||Rheumatoid arthritis||Clinical Phase I||
|BCW100002||Ischemic cerebrovascular disease||Clinical Phase II||
|BCW100003||Renal insufficiency||Clinical Phase II||
|BCW100005||Ischemia reperfusion injury caused by acute myocardial infarction||IIa||